Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Evotec joins list of recent cyberattack targets in pharma

By Brian Buntz | April 7, 2023

Double exposure microscope and Young woman scientific using equi

[Teerayut/Adobe Stock]

Evotec SE (Nasdaq:EVO), the German biotechnology company, recently succumbed to a cyberattack. Its Nasdaq shares appeared to be unaffected by the revelation, which described a IT network intrusion occurring on April 6. In a communiqué, the company said it preemptively shut down its IT systems as a result of the attack, disconnecting  them from the internet. Evotec noted that its IT team is currently examining its IT systems to review the scope of the attack. “Highest diligence will be applied to data integrity,” it added in an announcement.  

In an update released on April 10, Evotech said it was working with external IT specialists to investigate the recent cyberattack and maintain business continuity across its global operations. The company has informed relevant authorities and taken IT systems offline to ensure data integrity.

Evotech said it had disconnected selected IT systems, but that it maintains business continuity at all global sites, prioritizing data integrity.

Cyberattack targeting Evotec part of a larger trend

The Evotec network breach follows similar incidents at Sun Pharma (NSE:SUNPHARMA) and Alliance Healthcare in March. 

In early March 2023, Sun Pharma disclosed a ransomware attack that compromised some of its file systems. The company noted that it segregated the impacted IT systems from the internet and discovered the theft of company and personal data.

The cyberattack Alliance Healthcare resulted in shutting down the company’s website, billing systems and ordering processes, hindering Spain’s drug distribution supply chain.

Attacks on the pharma sector have ramped up during the pandemic, highlighting the industry’s vulnerability and the need for robust security measures to protect sensitive information.

Protecting sensitive data: Lessons from recent cyberattacks

Cyber-breaches can be especially expensive, as IBM’s Cost of a Data Breach 2022 report reveals. In 2022, healthcare breach costs reached a record high, averaging $10.10 million per incident. Financial organizations followed with average costs of $5.97 million, and pharmaceuticals at $5.01 million. 

Hamburg, Germany–based Evotec specializes in drug discovery and development. The company’s clients include all of the top 20 pharma companies, according to its website. Sun Pharma is one of the largest generic drugs makers while Alliance Healthcare is a leading pharmaceutical company in Spain, operating as a distributor and clinical trial support provider. 

Cybercriminals have also ramped up their focus on other organizations within the life sciences industry in recent years. A recent Lancet article describes an attack on the Lehigh Valley Health Network (LVHN) in Pennsylvania. Cyber researchers believe that BlackCat, a gang associated with Russia, was behind the incident. In this episode involving the health network, the malicious actors released sensitive clinical images and patient information on the dark web, demanding a ransom payment. LVHN refused to pay and is working with law enforcement and cybersecurity experts to investigate the incident. 

The medical device company Zoll Medical was recently sued in U.S. District Court in Eastern Massachusetts over a recent data breach involving more than 1 million people.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE